CellentraTech Files Patent Application Covering W2993, Advancing Intellectual Property Strategy for Lead KRAS G12D Program
CellentraTech Files Patent Application Covering W2993, Advancing Intellectual Property Strategy for Lead KRAS G12D Program
CellantraTech Therapeutics is a preclinical biotechnology company building a reusable nonviral delivery platform and two co-lead oncology programs.